Key Takeaways

• Women comprised approximately 70% of participants in the SCALE clinical trials and showed strong response rates, with 65% achieving at least 5% weight loss .
• Saxenda is contraindicated during pregnancy and breastfeeding. Women of childbearing age should use reliable contraception during treatment .
• Hormonal fluctuations during the menstrual cycle can affect appetite, nausea, and weight fluctuations, but do not reduce Saxenda's overall effectiveness.
• Women are more susceptible to certain Saxenda side effects, including gallstone formation (2.5 times higher risk with rapid weight loss) and hair thinning related to caloric deficit.
• PCOS (polycystic ovary syndrome), the most common endocrine disorder in women of reproductive age, responds favorably to GLP-1 therapy through improved insulin sensitivity and weight reduction.
• Personalized care through Form Blends accounts for the hormonal and metabolic factors unique to women's weight management.

How Women Respond to Saxenda

Women and men lose weight through the same fundamental mechanism on Saxenda (appetite suppression via GLP-1 receptor activation), but several biological differences affect how the experience unfolds:

Body Composition Differences

Women typically have a higher percentage of body fat and lower lean muscle mass than men at the same BMI. This means women's resting metabolic rate is generally lower, creating a smaller baseline caloric deficit for a given amount of appetite suppression. However, in percentage terms, women often match or slightly exceed men's results in the SCALE trials because they start with more proportional fat to lose.

Hormonal Appetite Regulation

Estrogen and progesterone both influence appetite, food preferences, and metabolism throughout the menstrual cycle. During the luteal phase (the two weeks before menstruation), progesterone rises and often increases hunger, cravings for carbohydrate-rich foods, and water retention. Saxenda can help blunt these cyclical appetite surges, though some women report that the medication feels less effective during this phase.

A practical tip: do not judge your Saxenda results based on a single week's weigh-in, especially during the premenstrual or menstrual phase. Water retention can mask several pounds of actual fat loss. Monthly averages are far more reliable than weekly snapshots for women.

Menopause and Perimenopause

Women in perimenopause and menopause face additional weight management challenges. Declining estrogen levels promote visceral fat accumulation, reduce lean muscle mass, and alter insulin sensitivity . Saxenda addresses some of these issues through appetite suppression and improved insulin signaling, making it a valuable tool during this transitional period.

That said, menopausal women may experience slightly slower weight loss compared to premenopausal women on the same dose due to lower basal metabolic rate and hormonal shifts. Combining Saxenda with resistance training is especially important for this group to preserve bone density and muscle mass.

Pregnancy, Fertility, and Breastfeeding

Reproductive considerations are critical for women of childbearing age on Saxenda:

Pregnancy

Saxenda is classified as a pregnancy risk and should be stopped at least 2 months before a planned pregnancy. Animal studies showed fetal harm at clinical doses, and there are no adequate human studies . If you become pregnant while on Saxenda, stop the medication immediately and contact your provider. The short half-life (13 hours) means liraglutide clears the system within 2 to 3 days of the last injection.

Fertility

Here is the good news: weight loss itself often improves fertility. Obesity is a leading cause of anovulation (failure to ovulate) and reduces success rates for both natural conception and assisted reproduction. Women who lose even 5 to 10% of body weight on Saxenda may experience restored ovulation and improved fertility .

This creates an important paradox: Saxenda can improve your ability to get pregnant while being a medication you cannot take during pregnancy. Women trying to conceive should use Saxenda to reach a healthier weight, then transition off the medication at least 2 months before attempting pregnancy. Use reliable contraception during treatment.

Breastfeeding

Saxenda is not recommended during breastfeeding. It is unknown whether liraglutide passes into breast milk, and the potential effects on a nursing infant have not been studied. If weight management is needed during breastfeeding, discuss alternative approaches with your provider .

PCOS and Saxenda

Polycystic ovary syndrome affects 6 to 12% of women of reproductive age and is strongly linked to insulin resistance, weight gain, and difficulty losing weight . GLP-1 receptor agonists like Saxenda address multiple PCOS pathways:

• Improved insulin sensitivity: Liraglutide reduces insulin resistance, which is the metabolic driver of PCOS in many women. Lower insulin levels reduce androgen production from the ovaries.
• Weight loss: Even modest weight loss (5 to 7%) can restore ovulatory cycles in many women with PCOS.
• Reduced androgen levels: Studies show that GLP-1 therapy reduces testosterone levels in women with PCOS, improving symptoms like acne and hirsutism .
• Improved menstrual regularity: Weight loss plus improved insulin signaling often restores more regular menstrual cycles.

While Saxenda is not FDA-approved specifically for PCOS, many providers prescribe it when PCOS coexists with obesity (BMI 30+) or overweight with comorbidities (BMI 27+). The dual benefit of weight loss plus metabolic improvement makes it a logical choice for this population.

Women-Specific Side Effects

Gallstone Formation

Women are already at higher risk for gallstones than men (approximately 2 times the risk), and rapid weight loss further increases this risk. In the SCALE trials, cholelithiasis (gallstones) occurred in 2.5% of Saxenda patients versus 0.8% on placebo . Symptoms include sharp pain in the upper right abdomen, nausea, and pain after eating fatty foods. Report these symptoms to your provider immediately.

Risk reduction strategies: maintain steady rather than rapid weight loss (1 to 2 pounds per week), stay hydrated, include moderate amounts of healthy fat in your diet (fat-free diets increase gallstone risk), and maintain fiber intake.

Hair Thinning (Telogen Effluvium)

Hair loss during weight loss is not caused by Saxenda directly but by the caloric deficit and nutritional changes that accompany rapid weight loss. The condition, called telogen effluvium, occurs 2 to 4 months after the body experiences metabolic stress (including significant caloric restriction). It affects women more noticeably because they tend to have longer hair and are more attuned to changes in hair volume.

Prevention strategies: ensure adequate protein (1.0 to 1.2 g/kg ideal body weight), take a multivitamin with iron and biotin, ensure adequate zinc intake, and avoid crash dieting. Hair typically regrows once weight stabilizes and nutrition normalizes.

Menstrual Cycle Changes

Some women report changes in menstrual cycle length, flow, or regularity when starting Saxenda. This is likely related to the weight loss itself (body fat plays a role in estrogen production) rather than a direct effect of liraglutide. Significant weight loss can temporarily alter cycle regularity before normalizing at the new weight. If cycle changes are concerning, consult your gynecologist.

Bone Density Considerations

Women, particularly those in perimenopause and beyond, should be aware that significant weight loss can accelerate bone mineral density loss. Weight-bearing exercise (walking, strength training) and adequate calcium (1,000 to 1,200 mg/day) and vitamin D (2,000 to 5,000 IU/day) intake help protect bone health during weight loss on Saxenda.

Nutrition Focus for Women on Saxenda

A daily multivitamin designed for women, plus additional vitamin D and omega-3 supplementation, covers most gaps when combined with a protein-forward whole-food diet. Your provider at Form Blends can recommend specific supplements based on your lab work and dietary patterns.

Exercise Recommendations for Women

The exercise prescription for women on Saxenda emphasizes three priorities: preserving lean muscle, protecting bone density, and maximizing metabolic health.

• Resistance training (2 to 3 sessions per week): This is non-negotiable. Women lose lean mass faster than men during caloric restriction, and resistance training is the most effective countermeasure. Focus on compound movements: squats, deadlifts, rows, presses, and lunges. You do not need heavy weights to start; bodyweight exercises and resistance bands work well for beginners.
• Moderate cardio (150 minutes per week): Walking, cycling, swimming, or elliptical training. This supports cardiovascular health and contributes to the caloric deficit without excessive stress on the body.
• Impact activities for bone health: Walking, jogging, dancing, and stair climbing are weight-bearing activities that stimulate bone maintenance. This is especially important for women over 40.
• Flexibility and recovery: Yoga, stretching, and foam rolling support joint health and recovery, particularly important as the body adapts to a new exercise routine during weight loss.

Frequently Asked Questions

Does Saxenda affect birth control effectiveness?

Saxenda slows gastric emptying, which theoretically could affect the absorption of oral contraceptives taken at the same time. As a precaution, take oral birth control pills at least one hour before your Saxenda injection. Non-oral contraceptive methods (IUD, implant, injection, patch) are not affected by gastric emptying changes .

Is Saxenda safe for women over 50?

Yes, with appropriate monitoring. Women over 50 should have a baseline bone density scan (DEXA) before starting, ensure adequate calcium and vitamin D intake, and prioritize resistance training. The benefits of treating obesity (reduced cardiovascular risk, improved mobility, better metabolic health) generally outweigh the risks in this age group.

Will Saxenda help with menopause-related weight gain?

Saxenda can help manage menopause-related weight gain by suppressing the increased appetite that often accompanies hormonal changes. However, it does not address the hormonal root causes of menopausal weight redistribution. Women in menopause often benefit from combining Saxenda with hormone replacement therapy (HRT) when appropriate, along with resistance training to combat muscle loss.

Does Saxenda affect my hormones?

Liraglutide does not directly alter estrogen, progesterone, or testosterone levels. However, the weight loss it promotes can indirectly improve hormonal balance by reducing excess estrogen produced by fat tissue, lowering testosterone in women with PCOS, and improving insulin levels that drive hormonal imbalances.

Can I take Saxenda while trying to conceive?

You should stop Saxenda at least 2 months before actively trying to conceive. However, using Saxenda to lose weight in preparation for pregnancy can significantly improve fertility outcomes. Work with your provider to create a timeline: lose weight on Saxenda, transition off the medication, then begin trying to conceive once liraglutide has cleared your system.

Why am I gaining weight before my period while on Saxenda?

Premenstrual weight gain (typically 2 to 5 pounds) is caused by water retention from progesterone and estrogen fluctuations, not fat gain. This happens regardless of Saxenda use. The weight will drop after menstruation begins. Track your weight on a monthly average basis rather than reacting to weekly fluctuations.

Start Your Weight Loss Journey with Care Designed for Women

Women's weight management requires attention to hormonal health, nutritional needs, reproductive planning, and body composition that generic weight loss programs often overlook. At Form Blends, our physicians understand these nuances and build treatment plans that account for the full picture of women's health. Begin with a consultation to learn whether Saxenda fits your goals and health profile.